Growing community of inventors

Fukuoka, Japan

Kensuke Egashira

Average Co-Inventor Count = 1.48

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 56

Kensuke Egashira ↔ Yoshiyuki Inada (1 patent)Kensuke Egashira ↔ Yoshikazu Yonemitsu (1 patent)Kensuke Egashira ↔ Katsuo Sueishi (1 patent)Kensuke Egashira ↔ Yasuhiro Ikeda (1 patent)Kensuke Egashira ↔ Shujiro Inoue (1 patent)Kensuke Egashira ↔ Junji Kojima (1 patent)Kensuke Egashira ↔ Megumi Sakamoto (1 patent)Kensuke EgashiraKensuke Egashira (4 patents)Yoshiyuki InadaYoshiyuki Inada (17 patents)Yoshikazu YonemitsuYoshikazu Yonemitsu (15 patents)Katsuo SueishiKatsuo Sueishi (4 patents)Yasuhiro IkedaYasuhiro Ikeda (2 patents)Shujiro InoueShujiro Inoue (1 patent)Junji KojimaJunji Kojima (1 patent)Megumi SakamotoMegumi Sakamoto (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Takeda Chemical Industries, Inc. (1 from 1,858 patents)

2. Takeda Pharmaceutical Company Limited (1 from 1,178 patents)

3. Kowa Company Limited (1 from 590 patents)

4. Kyushu University (1 from 431 patents)

5. Anges Mg, Inc. (1 from 29 patents)

6. Sentaniryoukaihatsu Co., Ltd. (1 from 1 patent)

7. Kensuke Egashira (1 from 1 patent)


4 patents:

1. 10568860 - Pharmaceutical composition containing statin-encapsulated nanoparticle

2. 8337896 - Drug-containing nanoparticles

3. 7345158 - Actin related cytoskeletal protein 'LACS'

4. 7309693 - Preventives and remedies for pulmonary hypertension

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/12/2025
Loading…